Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports worldwide in the next 60 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
12 companies reporting in the next 60 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Aug 27 · Earnings today · 1 company | |||||
| CUV.AX | Clinuvel Pharmaceuticals Limited | Rare disease | $338.48M | −2.40% | |
| Wednesday, Sep 16 · in 20 days · 1 company | |||||
| RZLT | Rezolute, Inc. | Rare disease | $485.31M | +2.44% | |
| Monday, Sep 21 · in 25 days · 2 companies | |||||
| ABVX.PA | ABIVAX Société Anonyme | Rare disease | $10.21B | −5.63% | |
| 2X1.DE | ABIVAX Société Anonyme | Rare disease | |||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| — |
| −6.77% |
| Wednesday, Sep 23 · in 27 days · 1 company | |||||
| INM | InMed Pharmaceuticals Inc. | Rare disease | $7.64M | −14.37% | |
| Thursday, Sep 24 · in 28 days · 1 company | |||||
| 0AB6.L | Hyloris Pharmaceuticals SA | Rare disease | $185.32M | −1.79% | |
| Tuesday, Sep 29 · in 33 days · 2 companies | |||||
| GNFT.PA | Genfit S.A. | Rare disease | $830.56M | +5.30% | |
| XUP.DE | Genfit S.A. | Rare disease | $258.22M | −1.81% | |
| Thursday, Oct 22 · in 56 days · 2 companies | |||||
| ARGX | argenx SE | Rare disease | $65.51B | +20.05% | |
| 1AE.DE | argenx SE | Rare disease | — | +15.89% | |
| Monday, Oct 26 · in 60 days · 2 companies | |||||
| BMRN | BioMarin Pharmaceutical Inc. | Rare disease | $12.70B | +5.70% | |
| 0HNC.L | BioMarin Pharmaceutical Inc. | Rare disease | $9.93B | +0.05% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.